(Reuters) – Lexicon Pharmaceuticals Inc said on Tuesday France’s Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista. Shares of Lexicon jumped 37.8% to $2.37 in after hours trading. Under th... More »
(Reuters) – French drugmaker Sanofi SA said on Friday it had terminated its partnership with Lexicon Pharmaceuticals Inc to develop and manufacture a drug for use with insulin in patients with type 1 and type 2 diabetes. Lexicon shares fell nearly 40% in exten... More »
JERUSALEM (Reuters) – Teva Pharmaceutical Industries’ chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 U.S. states. Mike McClellan told a conference in Israel that the suit w... More »
(Reuters) – Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioid overdose, the health regulator said. This is the first approval of a gene... More »
(Reuters) – A federal judge on Wednesday overturned a U.S. jury’s verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg. U.S. District Judge Leo... More »
A tourist poses for a photo with Teva Pharmaceutical Industries employees protesting outside Jerusalem’s Old City December 24, 2017. REUTERS/Amir Cohen TEL AVIV (Reuters) – Israel’s largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Ph... More »
A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi/File Photo (Reuters) – Canadian drugmaker Valeant Pharmaceuticals International Inc said the U.S. Food and Drug Administr... More »
(Reuters) – La Jolla Pharmaceutical said on Thursday the U.S. Food and Drug Administration had approved its drug, Giapreza, to treat dangerously low blood pressure. The company said it plans to make Giapreza available for patients in the United States in March... More »
Workers of Teva Pharmaceutical Industries and their relatives demonstrate at the entrance to the company’s facility in Ashdod, Israel December 17, 2017. REUTERS/Amir Cohen JERUSALEM (Reuters) – Workers at Israel’s Teva Pharmaceutical Industries (TEVA.TA) prote... More »
FILE PHOTO: The logo of Teva Pharmaceutical Industries, the world’s biggest generic drugmaker and Israel’s largest company, is seen in Jerusalem February 8, 2017. REUTERS/Ronen Zvulun/File Photo TEL AVIV (Reuters) – Teva Pharmaceutical Industries is expected t... More »
Teva Pharmaceutical Industries Ltd named H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president on Monday, as it struggles with heavy debts and fierce competition for its generic drugs in the United States. More »
A building belonging to Teva Pharmaceutical Industries, the world’s biggest generic drugmaker and Israel’s largest company, is seen in Jerusalem February 8, 2017. EU antitrust regulators charged Israeli drugmaker Teva (TEVA.TA) (TEVA.N) on Monday with doing an... More »
German drugs packager Gerresheimer has acquired an exclusive license for a syringe-safety solution from U.S.-based West Pharmaceutical Services, completing its portfolio of pre-fillable glass and plastic syringes, it said on Monday. More »
FILE PHOTO – William Ackman, chief executive of Pershing Square walks on the floor of the New York Stock Exchange, New York, U.S. on November 10, 2015. REUTERS/Brendan McDermid/File Photo Bayliss and Michael Flaherty More »
The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc’s oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors. More »
Logos of Japanese Takeda Pharmaceutical Co are seen at an office building in Glattbrugg near Zurich March 7, 2012. REUTERS/Arnd Wiegmann/File Photo – RTX2RH16 Japan’s Takeda Pharmaceutical Co (4502.T) flagged its appetite for fresh acquisitions to bolster its ... More »
U.S. Food and Drug Administration staff released voting questions on Teva Pharmaceutical Industries Ltd’s long-acting opioid painkiller for a panel of independent experts who will recommend to the agency whether to approve the drug. An FDA spokesman on Friday ... More »
MUMBAI Shares in India’s largest drugmaker, Sun Pharmaceutical Industries Ltd, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India’s generic drug industry. The warning comes bare... More »
